NCT04268498 2026-03-24
ADVANCE
University of Miami
Phase 2 Active not recruiting
Clinical Trials
21 trialsNCT02439034 2026-03-16
KETOCOL
Centre Oscar Lambret
Phase 2 Completed
NCT06043323 2026-03-12
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT05896228 2026-03-11
Iber-KDd
University of Miami
Phase 2 Recruiting
NCT03913559 2026-02-12
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Phase 2 Terminated
NCT05842044 2025-09-05
No-PAIN
University of Miami
Phase 2 Recruiting
NCT00712712 2025-08-29
MEDOR
Institut Bergonié
Phase 2 Completed
NCT03084536 2024-12-24
PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
Washington University School of Medicine
Phase 2 Completed
NCT05298683 2022-03-28
A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor
Hellenic Society of Hematology
Phase 2 Unknown
NCT00324467 2021-07-22
LYTPET
British Columbia Cancer Agency
Phase 2 Unknown
NCT02532322 2021-04-08
Efficacy of Acetaminophen in Posterior Fossa Surgery
Children's National Research Institute
Phase 2 Withdrawn
NCT00185692 2019-12-04
Allogeneic Transplantation From Related Haploidentical Donors
Stanford University
Phase 2 Completed
NCT02839668 2019-10-29
TIVA/TCI-BC
Iuliu Hatieganu University of Medicine and Pharmacy
Phase 2 Completed
NCT03111186 2019-09-26
Ibuprofen Plus Acetaminophen Versus Oxycodone Alone After Hand Surgery
University of Southern California
Phase 2 Completed
NCT00482053 2018-05-14
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
Stanford University
Phase 2 Terminated
NCT00186628 2017-11-28
Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Stanford University
Phase 2 Completed
NCT00899847 2017-10-20
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Stanford University
Phase 2 Completed
NCT00490009 2017-03-30
Phase 2 Study of Bexxar in Relapsed/Refractory DLCL
Stanford University
Phase 2 Completed
NCT01474304 2016-09-29
IVAC
Swedish Medical Center
Phase 2 Unknown
NCT02252926 2016-08-16
Local Anesthetic Treatment of Oral Pain in Patients With Mucositis
Hvidovre University Hospital
Phase 2 Completed
NCT00003346 2013-06-25
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed